XERMELO
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for XERMELO, covering 2017-02-28 to 2025-12-08. Get the full timeline:
Most recent: EMA Authorised: Xermelo (telotristat etiprate) — SERB SAS
7 regulatory and trial events tracked for XERMELO, covering 2017-02-28 to 2025-12-08. Get the full timeline:
Most recent: EMA Authorised: Xermelo (telotristat etiprate) — SERB SAS